Breaking News Instant updates and real-time market news.

AMGN

Amgen

$200.94

-0.54 (-0.27%)

16:04
01/24/19
01/24
16:04
01/24/19
16:04

Amgen receives NMPA approval for Repatha in China

Amgen announced that the National Medical Products Administration has approved a new indication for Repatha as the first PCSK9 inhibitor in China for adults with established atherosclerotic cardiovascular disease to reduce the risk of myocardial infarction, stroke and coronary revascularization. Low-density lipoprotein cholesterol is one of the key modifiable risk factors for the development of cardiovascular disease.Repatha lowers LDL-C.The approval of the extended label recognizes the positive findings from the 27,564-patient Repatha cardiovascular outcomes study. Patients on Repatha in combination with statin therapy, experienced a reduction in the risk of heart attack by 27%, the risk of stroke by 21% and the risk of coronary revascularization by 22%. Results from a FOURIER subanalysis demonstrated consistent efficacy and safety in the reduction of cardiovascular events using Repatha in Asian populations versus those from non-Asian backgrounds.

  • 28

    Jan

AMGN Amgen
$200.94

-0.54 (-0.27%)

01/22/19
PIPR
01/22/19
NO CHANGE
PIPR
Overweight
Piper says Alexion should be bought on EU patent decision headline weakness
Following news that the European Patent Office revoked Alexion's (ALXN) '834 Soliris formulation patent, Piper Jaffray analyst Christopher Raymond noted that the patent has been the subject of an opposition by Amgen (AMGN) in its effort to introduce a biosimilar version of Soliris in Europe. While the headline is "scary," the impact "could be essentially zero," as the appeals process could take 3-5 years, Soliris has EU Orphan data exclusivity for aHUS through November of 2023, so the earliest a biosimilar could receive approval in this indication is likely 2024, and Amgen still needs to run a trial, Raymond tells investors. Given that he sees "extremely limited impact" on Alexion's EU franchise from this 'decision, Raymond said he would be a buyer on weakness and keeps an Overweight rating on Alexion shares.
01/04/19
CANT
01/04/19
NO CHANGE
Target $100
CANT
Overweight
Cantor Fitzgerald analysis suggests others could bid for Celgene
Cantor Fitzgerald analyst Alethia Young reiterates an Overweight rating on Celgene (CELG) with a $100 price target after the company reached an agreement to be acquired by Bristol-Myers Squibb (BMY). Bristol "likely got a good deal, although Celgene has intellectual property and pipeline uncertainties that are key moving pieces," Young tells investors in a research note. Her estimated net present value for Celgene is $80B, assuming some cost synergies, versus the $74B equity valuation in the Bristol deal, excluding the contingent value rights. Young's analysis indicates that companies like Amgen (AMGN) and Johnson & Johnson (JNJ) "could potentially achieve greater commercial synergies." However, the analyst thinks Celgene shareholders "may be satisfied with the current deal after quite a roller-coaster over the past 18 months."
12/20/18
WELS
12/20/18
NO CHANGE
WELS
Drug industry facing 'brave new world' with drug price scrutiny, says Wells
After Reuters reported that nearly 30 drugmakers are planning to raise the prices of their medicines in the U.S. starting in January, including Novartis (NVS), Bayer (BAYRY), GlaxoSmithKline (GSK), Amgen (AMGN), AstraZeneca (AZN), Biogen (BIIB) and Allergan (AGN), Wells Fargo analyst David Maris told investors in a research note that he has repeatedly highlighted how the practice of drug price increases is a risk for the industry, and believes the latest actions by these manufacturers will be "front and center" for the Trump administration heading towards an election year. He also expects to see increased political and legislative pressure on drug prices as Democrats take over the House in January, and continues to believe that the drug industry is facing a "brave new world" with greater scrutiny of drug prices, lower price increases vs. historical levels, and as a result potentially lower profit margins.
12/18/18
HCWC
12/18/18
DOWNGRADE
HCWC
Neutral
Advaxis downgraded to Neutral from Buy at H.C. Wainwright
H.C. Wainwright analyst Swayampakula Ramakanth downgraded Advaxis (ADXS) to Neutral without a price target. Amgen's (AMGN) termination of a development and collaboration agreement puts ADXS-NEO in limbo, Ramakanth tells investors in a research note. The analyst believes Amgen's withdrawal has "considerably increased" the development risk on ADXS-NEO and potentially ADXS-HOT as well. He steps to the sidelines "until the viability of the programs can be assured."

TODAY'S FREE FLY STORIES

TLRD

Tailored Brands

$7.66

-0.41 (-5.08%)

13:05
03/20/19
03/20
13:05
03/20/19
13:05
Options
Tailored Brands call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HIIQ

Health Insurance Innovations

$29.13

-3.5 (-10.73%)

12:55
03/20/19
03/20
12:55
03/20/19
12:55
Options
Health Insurance Innovations put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

DRI

Darden

$108.53

-1.88 (-1.70%)

, CAG

Conagra Brands

$22.72

-0.09 (-0.39%)

12:53
03/20/19
03/20
12:53
03/20/19
12:53
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

DRI

Darden

$108.53

-1.88 (-1.70%)

CAG

Conagra Brands

$22.72

-0.09 (-0.39%)

CMC

Commercial Metals

$15.86

-0.26 (-1.61%)

GIII

G-III Apparel

$34.73

-0.83 (-2.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

  • 21

    Mar

  • 21

    Mar

  • 21

    Mar

MU

Micron

$39.75

-0.63 (-1.56%)

, WSM

Williams-Sonoma

$56.40

-0.39 (-0.69%)

12:53
03/20/19
03/20
12:53
03/20/19
12:53
Earnings
Notable companies reporting after market close »

Notable companies…

MU

Micron

$39.75

-0.63 (-1.56%)

WSM

Williams-Sonoma

$56.40

-0.39 (-0.69%)

GES

Guess

$22.02

-0.49 (-2.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 20

    Mar

  • 20

    Mar

  • 02

    Apr

  • 03

    Apr

  • 28

    May

ULTA

Ulta Beauty

$334.29

0.14 (0.04%)

, AMZN

Amazon.com

$1,775.60

13.15 (0.75%)

12:47
03/20/19
03/20
12:47
03/20/19
12:47
Recommendations
Ulta Beauty, Amazon.com, e.l.f. Beauty, Revlon, Estee Lauder, Coty analyst commentary  »

Amazon risk still…

ULTA

Ulta Beauty

$334.29

0.14 (0.04%)

AMZN

Amazon.com

$1,775.60

13.15 (0.75%)

ELF

e.l.f. Beauty

$9.73

0.495 (5.36%)

REV

Revlon

$19.49

1.47 (8.16%)

EL

Estee Lauder

$158.67

-2.03 (-1.26%)

COTY

Coty

$11.42

-0.08 (-0.70%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 26

    Mar

  • 04

    Apr

  • 01

    May

  • 28

    May

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$281.08

-1.4 (-0.50%)

12:43
03/20/19
03/20
12:43
03/20/19
12:43
Periodicals
Trump says tariffs on China could last for long period of time »

President Trump, speaking…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$281.08

-1.4 (-0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONCE

Spark Therapeutics

$113.52

-0.22 (-0.19%)

12:40
03/20/19
03/20
12:40
03/20/19
12:40
Options
Deal hedge opened in Spark Therapeutics »

Deal hedge opened in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VOD

Vodafone

$19.29

0.07 (0.36%)

, LBTYA

Liberty Global

$26.07

-0.08 (-0.31%)

12:39
03/20/19
03/20
12:39
03/20/19
12:39
Periodicals
EC to issue statement of objections on Vodafone, Liberty deal, Reuters says »

EU antitrust regulators…

VOD

Vodafone

$19.29

0.07 (0.36%)

LBTYA

Liberty Global

$26.07

-0.08 (-0.31%)

LBTYK

Liberty Global

$25.40

-0.06 (-0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$39.81

-0.57 (-1.41%)

, SSNLF

Samsung

$0.00

(0.00%)

12:37
03/20/19
03/20
12:37
03/20/19
12:37
Earnings
Fly Intel: What to watch in Micron's earnings report »

Micron (MU) is scheduled…

MU

Micron

$39.81

-0.57 (-1.41%)

SSNLF

Samsung

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 20

    Mar

  • 28

    May

VOD

Vodafone

$19.30

0.08 (0.42%)

, LBTYA

Liberty Global

$26.03

-0.12 (-0.46%)

12:35
03/20/19
03/20
12:35
03/20/19
12:35
Periodicals
Breaking Periodicals news story on Vodafone, Liberty Global »

EC to issue statement of…

VOD

Vodafone

$19.30

0.08 (0.42%)

LBTYA

Liberty Global

$26.03

-0.12 (-0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$281.11

-1.37 (-0.48%)

, SPX

S&P 500

$0.00

(0.00%)

12:34
03/20/19
03/20
12:34
03/20/19
12:34
General news
Breaking General news story on SPDR S&P 500 ETF Trust, S&P 500 »

Trump says tariffs to…

SPY

SPDR S&P 500 ETF Trust

$281.11

-1.37 (-0.48%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALLY

Ally Financial

$26.57

-0.29 (-1.08%)

12:30
03/20/19
03/20
12:30
03/20/19
12:30
Options
Aggressive call buy in Ally Financial »

Aggressive call buy in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 18

    Apr

  • 28

    May

MSFT

Microsoft

$117.41

-0.31 (-0.26%)

, NTDOY

Nintendo

$0.00

(0.00%)

12:25
03/20/19
03/20
12:25
03/20/19
12:25
Periodicals
Former Microsoft exclusive 'Cuphead' coming to Nintendo Switch, Verge says »

Indie video game…

MSFT

Microsoft

$117.41

-0.31 (-0.26%)

NTDOY

Nintendo

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Apr

LB

L Brands

$27.53

-0.665 (-2.36%)

12:25
03/20/19
03/20
12:25
03/20/19
12:25
Options
L Brands call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

  • 23

    May

NTNX

Nutanix

$39.18

0.405 (1.04%)

12:25
03/20/19
03/20
12:25
03/20/19
12:25
Conference/Events
Nutanix to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 21

    Mar

  • 04

    Apr

  • 09

    Jul

EA

Electronic Arts

$96.97

-0.54 (-0.55%)

, GOOG

Alphabet

$1,206.40

6.69 (0.56%)

12:20
03/20/19
03/20
12:20
03/20/19
12:20
Recommendations
Electronic Arts, Alphabet, Alphabet Class A, Microsoft, Sony analyst commentary  »

Buckingham Neutral on…

EA

Electronic Arts

$96.97

-0.54 (-0.55%)

GOOG

Alphabet

$1,206.40

6.69 (0.56%)

GOOGL

Alphabet Class A

$1,210.03

6.9 (0.57%)

MSFT

Microsoft

$117.34

-0.38 (-0.32%)

SNE

Sony

$43.20

-2.3 (-5.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 04

    Apr

  • 29

    Apr

  • 29

    Apr

  • 27

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
03/20/19
03/20
12:17
03/20/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
03/20/19
03/20
12:16
03/20/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBS

CBS

$46.07

-1.09 (-2.31%)

12:15
03/20/19
03/20
12:15
03/20/19
12:15
Options
CBS put volume heavy and directionally bearish »

Bearish flow noted in CBS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

12:15
03/20/19
03/20
12:15
03/20/19
12:15
General news
Oil Action: WTI crude »

Oil Action: WTI crude has…

SQ

Square

$74.18

-2.56 (-3.34%)

12:06
03/20/19
03/20
12:06
03/20/19
12:06
Hot Stocks
Square announces new revamped Square Online Store and Square for retail »

Square announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FDP

Fresh Del Monte

$27.47

-0.36 (-1.29%)

12:04
03/20/19
03/20
12:04
03/20/19
12:04
Hot Stocks
Fresh Del Monte announces resignation of CFO »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

AMZN

Amazon.com

$1,778.51

16.06 (0.91%)

, DOMO

Domo

$43.20

-0.76 (-1.73%)

12:02
03/20/19
03/20
12:02
03/20/19
12:02
Hot Stocks
Domo announces integration with Amazon SageMaker »

Domo (DOMO) announced a…

AMZN

Amazon.com

$1,778.51

16.06 (0.91%)

DOMO

Domo

$43.20

-0.76 (-1.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 20

    Mar

  • 26

    Mar

  • 04

    Apr

  • 10

    Apr

FDX

FedEx

$172.31

-9.19 (-5.06%)

, GOOGL

Alphabet Class A

$1,212.82

9.69 (0.81%)

12:01
03/20/19
03/20
12:01
03/20/19
12:01
On The Fly
Fly Intel: Wall Street's top stories at midday »

Stocks have declined in…

FDX

FedEx

$172.31

-9.19 (-5.06%)

GOOGL

Alphabet Class A

$1,212.82

9.69 (0.81%)

GOOG

Alphabet

$1,209.05

9.34 (0.78%)

DIS

Disney

$110.34

0.365 (0.33%)

TFCF

21st Century Fox

$49.61

(0.00%)

NVRO

Nevro

$59.90

15.14 (33.82%)

GIS

General Mills

$49.18

1.94 (4.11%)

TDC

Teradata

$45.31

-3.02 (-6.25%)

SCS

Steelcase

$15.66

-1.825 (-10.44%)

TME

Tencent Music

$16.98

-1.67 (-8.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 20

    Mar

  • 20

    Mar

  • 20

    Mar

  • 21

    Mar

  • 27

    Mar

  • 01

    Apr

  • 02

    Apr

  • 04

    Apr

  • 11

    Apr

  • 29

    Apr

  • 29

    Apr

  • 30

    Apr

  • 14

    May

  • 24

    Jun

  • 25

    Jun

  • 26

    Jun

  • 27

    Oct

CEL

Cellcom Israel

$3.78

-0.29 (-7.13%)

12:00
03/20/19
03/20
12:00
03/20/19
12:00
Hot Stocks
Cellcom Israel falls -7.3% »

Cellcom Israel is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.